1235451-38-3

Basic information

• Product Name: N-Boc-5-BroMo-2-pyriMidineMethanaMine
• Synonyms: N-Boc-5-BroMo-2-pyriMidineMethanaMine;2-(Boc-aMinoMethyl)-5-broMopyriMidine;tert-Butyl ((5-broMopyriMidin-2-yl)Methyl)carbaMate;tert-butyl N-[(5-bromopyrimidin-2-yl)methyl]carbamate;tert-Butyl ((5-bromopyrimidin-2-yl)
• CAS NO: 1235451-38-3
• Molecular Formula: C10H14BrN3O2
• Molecular Weight: 288.14106
• Product Categories: pyrimidine;Heterocycle-Pyrimidine series
• Mol File: 1235451-38-3.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 367.3±22.0 °C(Predicted)
• Appearance: /
• Density: 1.417±0.06 g/cm3(Predicted)
• Storage Temp.: 2-8°C(protect from light)
• PKA: 11.25±0.46(Predicted)
• CAS DataBase Reference: N-Boc-5-BroMo-2-pyriMidineMethanaMine(CAS DataBase Reference)
• NIST Chemistry Reference: N-Boc-5-BroMo-2-pyriMidineMethanaMine(1235451-38-3)
• EPA Substance Registry System: N-Boc-5-BroMo-2-pyriMidineMethanaMine(1235451-38-3)

Safety Data

• Hazardous Substances Data: 1235451-38-3(Hazardous Substances Data)

Usage

General Description

N-Boc-5-Bromo-2-pyrimidinemethanamine is a chemical compound used as a building block in organic synthesis. It consists of a pyrimidine ring with a bromine atom and a N-Boc (tert-butoxycarbonyl) protective group attached to the nitrogen atom. The N-Boc group is commonly used to protect amines in organic reactions and can be easily removed under mild conditions. N-Boc-5-BroMo-2-pyriMidineMethanaMine can be used in the synthesis of various pharmaceuticals, agrochemicals, and other organic compounds. It is important for its versatility as a chemical intermediate in the production of a wide range of compounds.

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 1240783-02-1 (5-bromopyrimidin-2-yl)methylamine 
• 7752-78-5 5-bromo-2-methylpyrimidine 
• 100707-39-9 5-bromo-2-methyl-pyrimidine-4-carboxylic acid 
• 1193116-74-3 5-bromo-2-(bromomethyl)pyrimidine 

Relevant articles and documents

PHOSPHOINOSITIDE 3-KINASE INHIBITORS WITH ZINC BINDING MOIETY

PROBLEM TO BE SOLVED: To provide phosphoinositide 3-kinase inhibitors with a zinc binding moiety. SOLUTION: There is provided a compound represented by formula (I) in the figure. (X is S, O or the like; Y is CH, N or the like; G1 is optionally substituted N or the like; R1 and R2 are each independently H or the like; C is a substituted heterocycle or the like; B is a linear alkyl or the like; Ra and Rb together with the nitrogen atom coupled to them are morpholino or the like; G2 is an indazole ring or the like; q, r and s are independently from 0 to 1, provided that at least one of them is 1; t is from 0 to 1; n is from 0 to 4; and p is from 0 to 2.) COPYRIGHT: (C)2016,JPOandINPIT

TREATMENT OF CANCERS HAVING K-RAS MUTATIONS

The present invention provides a method of treating a cancer associated with a K- ras mutation in a subject in need thereof. The method comprises the steps of (1) identifying a subject with a cancer associated with a K-ras mutation; and (2) adminsiterign to the subject (i) an inhibitor of PI3 kinase and (ii) an HDAC inhibitor, wherein the PI3 kinase inhibitor and the HDAC inhibitor are administered in amounts which together are therapeutically effective.